Illustrative image – not actual.Hikal is likely to commission its multipurpose facility to manufacture active pharmaceutical ingredients (APIs) in Bangalore will be operational by June 2012.
The facility can accommodate 32 reactors with capacities ranging from 6 m3 to 10 m3. This will result in a total reactor volume of approximately 300m3. The facility will cater to the demand for a wide range of APIs from its customers in markets like the US, Europe, South East Asia, Latin America, Canada and Japan.
